SHILPAMED.NSSHILPAMED.NSNSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+25.8%
5Y CAGR+1.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+25.8%/yr
vs -3.7%/yr prior
5Y CAGR
+1.6%/yr
Recent acceleration
Acceleration
+29.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.72B | +101.5% |
| 2024 | $3.33B | +131.5% |
| 2023 | $1.44B | -57.3% |
| 2022 | $3.37B | -33.8% |
| 2021 | $5.10B | -17.9% |
| 2020 | $6.21B | +43.8% |
| 2019 | $4.32B | +9.9% |
| 2018 | $3.93B | +9.7% |
| 2017 | $3.58B | +33.8% |
| 2016 | $2.68B | - |